Claus B Pedersen - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Journal of the American Geriatrics Society|November 6, 2007

Lower risk of hypoglycemia with insulin detemir than with neutral protamine hagedorn insulin in older persons with type 2 diabetes: a pooled analysis of phase III trialsAlan J Garber, Per Clauson, Claus B Pedersen, et al.

American Journal of Human Genetics|March 17, 2004

Novel analytical methods applied to type 1 diabetes genome-scan dataFlemming Pociot, Allan E Karlsen, Claus B Pedersen, et al.

The British Journal of Dermatology|January 23, 2025

Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)Jonathan I Silverberg, Lawrence F Eichenfield, Andrew Blauvelt, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Journal of the American Geriatrics Society|November 6, 2007

Lower risk of hypoglycemia with insulin detemir than with neutral protamine hagedorn insulin in older persons with type 2 diabetes: a pooled analysis of phase III trialsAlan J Garber, Per Clauson, Claus B Pedersen, et al.

American Journal of Human Genetics|March 17, 2004

Novel analytical methods applied to type 1 diabetes genome-scan dataFlemming Pociot, Allan E Karlsen, Claus B Pedersen, et al.

The British Journal of Dermatology|January 23, 2025

Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)Jonathan I Silverberg, Lawrence F Eichenfield, Andrew Blauvelt, et al.

Pageof 1